# TK & Partners

> TK & Partners is a VC fund in Bangkok backing Energy and Medical. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Bangkok, Thailand
- Total investments: 3
- Last investment: Apr 2026
- Lead investor: 67%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/tk-and-partners/
- Website: https://tk-partners.co/

TK & Partners is a McKinsey venture capital firm.

## Contacts

5 contacts available for TK & Partners. Shizune tracks 1 team members at TK & Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/tk-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.5M–$4.3M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Energy | 1 | 33% |
| Medical | 1 | 33% |
| Health Care | 1 | 33% |
| Biotechnology | 1 | 33% |
| Machine Learning | 1 | 33% |

8 industries tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Singapore | 1 | 33% |
| United States | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Tomas Koch | Founder and Chairman | 3 | https://shizune.co/investors/profile/tomas-koch |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Acurion | Acurion develops AI-driven diagnostic solutions that extract actionable genomic biomarker insights from standard pathology images to inform oncology treatment decisions. The company’s core product, OncoGaze™, analyzes digitized tumor biopsy slides to identify clinically relevant molecular features such as homologous recombination deficiency thatguide therapy selection more rapidly than conventional genomic testing. Acurion’s platform integrates into existing clinical workflows to support earlier precision medicine decisions for cancer care and is being expanded to detect additional biomarkers across various tumor types. The company collaborates with research and clinical partners to advance applications of its machine learning technology in oncology and related areas. | $4.3M | Seed | Apr 02, 2026 |  |
| Acurion | Acurion develops AI-driven diagnostic solutions that extract actionable genomic biomarker insights from standard pathology images to inform oncology treatment decisions. The company’s core product, OncoGaze™, analyzes digitized tumor biopsy slides to identify clinically relevant molecular features such as homologous recombination deficiency thatguide therapy selection more rapidly than conventional genomic testing. Acurion’s platform integrates into existing clinical workflows to support earlier precision medicine decisions for cancer care and is being expanded to detect additional biomarkers across various tumor types. The company collaborates with research and clinical partners to advance applications of its machine learning technology in oncology and related areas. | $2.1M | Seed | Jan 02, 2026 |  |
| HYDGEN | HydGen offers clean hydrogen solutions for an environmentally conscious future. | $1.5M | Seed | Feb 13, 2025 |  |

3 of 3 investments shown.

## Co-investors
- [Asian Fund For Cancer Research](https://shizune.co/investors/profile/asian-fund-for-cancer-research) — VC Fund, 1 deal together
- [Bootstrap Venture Partners](https://shizune.co/investors/profile/bootstrap-venture-partners) — VC Fund, 1 deal together
- [Cloudberry Pioneer Investments](https://shizune.co/investors/profile/cloudberry-pioneer-investments) — VC Fund, 1 deal together
- [Mesa Verde Venture Partners](https://shizune.co/investors/profile/mesa-verde-venture-partners) — VC Fund, 1 deal together
- [National Foundation for Cancer Research](https://shizune.co/investors/profile/national-foundation-for-cancer-research) — VC Fund, 1 deal together
- [National University of Singapore](https://shizune.co/investors/profile/national-university-of-singapore) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Lowercarbon Capital](https://shizune.co/investors/profile/lowercarbon-capital) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Seeds Capital](https://shizune.co/investors/profile/seeds-capital) — VC Fund
- [Wavemaker Ventures](https://shizune.co/investors/profile/wavemaker-partners) — VC Fund

## Featured in investor lists
- [Renewable Energy Investors in Singapore](https://shizune.co/investors/renewable-energy-investors-singapore)
- [Renewable Energy VC Funds in Singapore](https://shizune.co/investors/renewable-energy-vc-funds-singapore)

## FAQ

### What does TK & Partners invest in?

TK & Partners invests primarily in Energy, Medical and Health Care startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is TK & Partners's check size?

TK & Partners typically joins rounds of $1.5M–$4.3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds TK & Partners participates in.

### How do I contact TK & Partners?

Public channels for TK & Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at TK & Partners?

The team at TK & Partners includes Tomas Koch (Founder and Chairman). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co